收费全文 | 9245篇 |
免费 | 640篇 |
国内免费 | 32篇 |
耳鼻咽喉 | 130篇 |
儿科学 | 309篇 |
妇产科学 | 310篇 |
基础医学 | 1310篇 |
口腔科学 | 461篇 |
临床医学 | 1054篇 |
内科学 | 1759篇 |
皮肤病学 | 163篇 |
神经病学 | 767篇 |
特种医学 | 197篇 |
外科学 | 798篇 |
综合类 | 65篇 |
一般理论 | 3篇 |
预防医学 | 1206篇 |
眼科学 | 100篇 |
药学 | 664篇 |
中国医学 | 32篇 |
肿瘤学 | 589篇 |
2023年 | 91篇 |
2022年 | 76篇 |
2021年 | 234篇 |
2020年 | 249篇 |
2019年 | 283篇 |
2018年 | 352篇 |
2017年 | 275篇 |
2016年 | 253篇 |
2015年 | 326篇 |
2014年 | 366篇 |
2013年 | 521篇 |
2012年 | 798篇 |
2011年 | 821篇 |
2010年 | 431篇 |
2009年 | 388篇 |
2008年 | 669篇 |
2007年 | 639篇 |
2006年 | 563篇 |
2005年 | 546篇 |
2004年 | 496篇 |
2003年 | 452篇 |
2002年 | 402篇 |
2001年 | 50篇 |
2000年 | 29篇 |
1999年 | 42篇 |
1998年 | 50篇 |
1997年 | 46篇 |
1996年 | 25篇 |
1995年 | 48篇 |
1994年 | 42篇 |
1993年 | 44篇 |
1992年 | 21篇 |
1991年 | 23篇 |
1990年 | 19篇 |
1989年 | 9篇 |
1988年 | 15篇 |
1987年 | 14篇 |
1986年 | 17篇 |
1985年 | 25篇 |
1984年 | 18篇 |
1983年 | 16篇 |
1982年 | 8篇 |
1981年 | 11篇 |
1980年 | 13篇 |
1979年 | 12篇 |
1978年 | 11篇 |
1976年 | 6篇 |
1975年 | 6篇 |
1974年 | 8篇 |
1971年 | 7篇 |
Stereotactic radiation therapy (SRT) and immune checkpoint inhibitors (ICI) may act synergistically to improve treatment outcomes but may also increase the risk of symptomatic radiation necrosis (RN). The objective of this study was to compare outcomes for patients undergoing SRT with and without concurrent ICI.
Methods and materialsPatients treated for BMs with single or multi-fraction SRT were retrospectively reviewed. Concurrent ICI with SRT (SRT-ICI) was defined as administration within 3 months of SRT. Local control (LC), radiation necrosis (RN) risk and distant brain failure (DBF) were estimated by the Kaplan-Meier method and compared between groups using the log-rank test. Wilcoxon rank sum and Chi-square tests were used to compare covariates. Multivariate cox regression analysis (MVA) was performed.
ResultsOne hundred seventy-nine patients treated with SRT for 385 brain lesions were included; 36 patients with 99 lesions received SRT-ICI. Median follow up was 10.3 months (SRT alone) and 7.7 months (SRT- ICI) (p = 0.08). Lesions treated with SRT-ICI were more commonly squamous histology (17% vs 8%) melanoma (20% vs 2%) or renal cell carcinoma (8% vs 6%), (p < 0.001). Non-small cell lung cancer (NSCLC) compromised 60% of patients receiving ICI (n = 59). Lesions treated with SRT-ICI had significantly improved 1-year local control compared to SRT alone (98 and 89.5%, respectively (p = 0.0078). On subset analysis of NSCLC patients alone, ICI was also associated with improved 1 year local control (100% vs. 90.1%) (p = 0.018). On MVA, only tumor size ≤2 cm was significantly associated with LC (HR 0.38, p = 0.02), whereas the HR for concurrent ICI with SRS was 0.26 (p = 0.08). One year DBF (41% vs. 53%; p = 0.21), OS (58% vs. 56%; p = 0.79) and RN incidence (7% vs. 4%; p = 0.25) were similar for SRT alone versus SRT-ICI, for the population as a whole and those patients with NSCLC.
ConclusionThese results suggest SRT-ICI may improve local control of brain metastases and is not associated with an increased risk of symptomatic radiation necrosis in a cohort of predominantly NSCLC patients. Larger, prospective studies are necessary to validate these findings and better elucidate the impact of SRT-ICI on other disease outcomes.
相似文献Methods: Patients with CoA who were registered at the ACHD clinic in Gothenburg were asked to participate in a comprehensive cardiovascular risk assessment. This assessment included a glucose tolerance test, cholesterol profile, ambulatory blood pressure measurements, and a lifestyle questionnaire.
Results: A total of 72 patients participated. The median age was 43.5 years and 58.3% were men. Sixty‐six (91.7%) patients had ≥one cardiovascular risk factor and 40.3% had ≥three risk factors. Three (4.2%) patients were newly diagnosed with diabetes or impaired glucose tolerance. More than half of the patients had hyperlipidemia (n = 42, 58.3%) and 35 patients (48.6%) were overweight or obese. Only three (4.2%) patients smoked regularly. Of the 60 patients who underwent 24‐hour ambulatory blood pressure measurement, 33 (55.0%) were hypertensive. Of the 30 patients with known hypertension only 9 (30.0%) had well‐controlled blood pressure on ambula‐ tory blood pressure measurement.
Conclusions: Cardiovascular risk factors among patients with CoA are prevalent. This may indicate a need for more aggressive screening strategies of traditional risk fac‐ tors to minimize the risk of these patients also developing atherosclerotic disease. 相似文献